Position in AMGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,612,520
+$64,381 QoQ
Shares Held
4,453
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#1,397
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 44%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. AMGN ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
This page
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
|
1,703 | $266,893 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,612,520 | 4,453 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,548,139 | 4,400 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,452,601 | 4,438 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,252,403 | 4,438 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,138,896 | 4,079 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,511,017 | 4,850 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,264,104 | 4,850 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,546,607 | 4,800 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,477,576 | 4,729 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,333,176 | 4,689 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,366,654 | 4,745 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,264,515 | 4,705 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $863,657 | 3,890 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $942,825 | 3,900 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $1,002,496 | 3,817 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $854,040 | 3,789 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $921,863 | 3,789 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $916,255 | 3,789 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $909,103 | 4,041 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,078,348 | 5,071 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,268,962 | 5,206 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,315,209 | 5,286 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,223,404 | 5,321 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,262,921 | 4,969 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $1,171,988 | 4,969 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,036,558 | 5,113 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||